Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer.
![Thumbnail](/bitstream/handle/internal/3012/nihms811145.pdf.jpg?sequence=60&isAllowed=y)
View/ Open
Date
2016-11-01ICR Author
Author
Painter, JN
O'Mara, TA
Marquart, L
Webb, PM
Attia, J
Medland, SE
Cheng, T
Dennis, J
Holliday, EG
McEvoy, M
Scott, RJ
Ahmed, S
Healey, CS
Shah, M
Gorman, M
Martin, L
Hodgson, SV
Beckmann, MW
Ekici, AB
Fasching, PA
Hein, A
Rübner, M
Czene, K
Darabi, H
Hall, P
Li, J
Dörk, T
Dürst, M
Hillemanns, P
Runnebaum, IB
Amant, F
Annibali, D
Depreeuw, J
Lambrechts, D
Neven, P
Cunningham, JM
Dowdy, SC
Goode, EL
Fridley, BL
Winham, SJ
Njølstad, TS
Salvesen, HB
Trovik, J
Werner, HMJ
Ashton, KA
Otton, G
Proietto, A
Mints, M
Tham, E
Bolla, MK
Michailidou, K
Wang, Q
Tyrer, JP
Hopper, JL
Peto, J
Swerdlow, AJ
Burwinkel, B
Brenner, H
Meindl, A
Brauch, H
Lindblom, A
Chang-Claude, J
Couch, FJ
Giles, GG
Kristensen, VN
Cox, A
Pharoah, PDP
Tomlinson, I
Dunning, AM
Easton, DF
Thompson, DJ
Spurdle, AB
AOCS Group,
for RENDOCAS,
National Study of Endometrial Cancer Genetics Group (NSECG),
Australian National Endometrial Cancer Study Group (ANECS),
Type
Journal Article
Metadata
Show full item recordAbstract
BACKGROUND: The strongest known risk factor for endometrial cancer is obesity. To determine whether SNPs associated with increased body mass index (BMI) or waist-hip ratio (WHR) are associated with endometrial cancer risk, independent of measured BMI, we investigated relationships between 77 BMI and 47 WHR SNPs and endometrial cancer in 6,609 cases and 37,926 country-matched controls. METHODS: Logistic regression analysis and fixed effects meta-analysis were used to test for associations between endometrial cancer risk and (i) individual BMI or WHR SNPs, (ii) a combined weighted genetic risk score (wGRS) for BMI or WHR. Causality of BMI for endometrial cancer was assessed using Mendelian randomization, with BMIwGRS as instrumental variable. RESULTS: The BMIwGRS was significantly associated with endometrial cancer risk (P = 3.4 × 10-17). Scaling the effect of the BMIwGRS on endometrial cancer risk by its effect on BMI, the endometrial cancer OR per 5 kg/m2 of genetically predicted BMI was 2.06 [95% confidence interval (CI), 1.89-2.21], larger than the observed effect of BMI on endometrial cancer risk (OR = 1.55; 95% CI, 1.44-1.68, per 5 kg/m2). The association attenuated but remained significant after adjusting for BMI (OR = 1.22; 95% CI, 1.10-1.39; P = 5.3 × 10-4). There was evidence of directional pleiotropy (P = 1.5 × 10-4). BMI SNP rs2075650 was associated with endometrial cancer at study-wide significance (P < 4.0 × 10-4), independent of BMI. Endometrial cancer was not significantly associated with individual WHR SNPs or the WHRwGRS. CONCLUSIONS: BMI, but not WHR, is causally associated with endometrial cancer risk, with evidence that some BMI-associated SNPs alter endometrial cancer risk via mechanisms other than measurable BMI. IMPACT: The causal association between BMI SNPs and endometrial cancer has possible implications for endometrial cancer risk modeling. Cancer Epidemiol Biomarkers Prev; 25(11); 1503-10. ©2016 AACR.
Collections
Subject
AOCS Group
for RENDOCAS
National Study of Endometrial Cancer Genetics Group (NSECG)
Australian National Endometrial Cancer Study Group (ANECS)
Humans
Endometrial Neoplasms
Obesity
Genetic Predisposition to Disease
Body Mass Index
Waist-Hip Ratio
Polymorphism, Single Nucleotide
Female
Mendelian Randomization Analysis
Research team
Aetiological Epidemiology
Language
eng
Date accepted
2016-06-15
License start date
2016-11
Citation
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016, 25 (11), pp. 1503 - 1510
Publisher
AMER ASSOC CANCER RESEARCH
Related items
Showing items related by title, author, creator and subject.
-
Five endometrial cancer risk loci identified through genome-wide association analysis.
Cheng, TH; Thompson, DJ; O'Mara, TA; Painter, JN; Glubb, DM; et al. (NATURE PORTFOLIO, 2016-06-01)We conducted a meta-analysis of three endometrial cancer genome-wide association studies (GWAS) and two follow-up phases totaling 7,737 endometrial cancer cases and 37,144 controls of European ancestry. Genome-wide imputation ... -
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.
Zhang, YD; Hurson, AN; Zhang, H; Choudhury, PP; Easton, DF; et al. (NATURE PORTFOLIO, 2020-07-03)Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of ... -
Magnetic resonance image guided adaptive radiotherapy for gynaecological and rectal cancer
Dearnaley, D; White, I (Institute of Cancer Research (University Of London), 2020-11-30)Multiple challenges exist in radiotherapy for gynaecological and rectal cancer. These lead to uncertainty and error in dose delivered to the tumour target and organs at risk (OARs). Adequate planning target volume (PTV) ...